Rapidly progressive glomerulonephritis diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(15 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Rapidly progressive glomerulonephritis}}
{{Rapidly progressive glomerulonephritis}}
{{CMG}}; {{APM}} {{AE}} {{KW}}, {{ADS}}, {{AEL}}  
{{CMG}}; {{APM}} {{AE}} {{KW}}, {{ADS}},  
 
{{AEL}}, {{N.F}}  


==Overview==
==Overview==
Rapid diagnosis of renalosteodystrophy is very crucial to save kidneys function ,
Rapid diagnosis of rapidly progressive glomerulonephritis is very crucial to save kidneys function. It includes blood workup and renal [[biopsy]].Renal [[biopsy]] will provide the definitive diagnosis about the extent of involvement. Sometimes the result can be delayed ,in such cases the emperative therapy should be started to prevent [[end stage renal disease]].


Serologic studies
== Diagnostic study of choice ==


Biopsy
==== Renal biopsy: ====
* [[Renal biopsy]] will provide the most accurate reslt.
* [[Renal biopsy]] will give accurate information about the extent of the disease and therapy can be planned accordingly.


Determination of [[antineutrophil cytoplasmic antibody|ANCA]]s can aid in the diagnosis, but positivity is not conclusive and negative ANCAs are not sufficient to reject the diagnosis. Cytoplasmic staining ANCAs that react with the enzyme [[proteinase 3]] (cANCA) in [[neutrophil granulocyte|neutrophils]] (a type of [[white blood cell]]) are associated with Granulomatosis with polyangiitis. If the patient has [[chronic renal failure|renal failure]] or cutaneous vasculitis, these are the most logical organs to obtain a [[biopsy]] from. Rarely, [[thoracoscopy|thoracoscopic]] lung biopsy is required.
* Findings include:<ref name="pmid12631105">{{cite journal |vauthors=Jennette JC |title=Rapidly progressive crescentic glomerulonephritis |journal=Kidney Int. |volume=63 |issue=3 |pages=1164–77 |date=March 2003 |pmid=12631105 |doi=10.1046/j.1523-1755.2003.00843.x |url=}}</ref>
** Diffuse [[inflammation]] in [[glomeruli]] with rupture and damage to [[glomerular]] basement membrane.
** [[Crescents]] are present in the [[Bowmans space]].
** Renal vessels can show [[transmural]] [[vasculitis]], with [[necrosis]] and [[lymphocyte]] infiltrates.
** [[Tubular]] necrosis may also be present.
** [[Interstitial granulomas]] in the [[glomeruli]] indicate [[Wegener’s granulomatosis]].
[[File:192px-Crescentic glomerulonephritis (1).jpg|200px|center|thumb| Microscopic findings of RPGN Source:By Nephron - Own work<ref>https://commons.wikimedia.org/w/index.php?curid=17591464 </ref>]]


==Diagnostic Criteria==
=====Immunoflourescence=====
A diagnosis of Granulomatosis with polyangiitis can be made when three out of the six criteria are established. They are:<ref name="pmid27596099">{{cite journal| author=Noone D, Hebert D, Licht C| title=Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement. | journal=Pediatr Nephrol | year= 2016 | volume=  | issue=  | pages=  | pmid=27596099 | doi=10.1007/s00467-016-3475-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27596099  }}</ref>
*In type I RPGN- diffuse and linear deposition of [[Immunoglobulin G|IgG]] along the [[GBM]].
# a histopathology that shows granuloma
*In ttype II RPGN- diffuse and irregular deposition of IgG and C3 in the [[Mesangial cell|mesangial]] matrix.
# the upper respiratory tract is involved
*In type III RPGN- no finding.
# there is a stenosis that is present in larynx, trachea, and the bronchioles
*'''Electron microscopy'''
# the pulmonary system is involved
*In type I and type III, no electron dense deposits are seen.
# the presence of anti-neutrophil cytoplasmic antibodies
**In type II RPGN, [[subepithelial]] electron dense deposits indiacting the presence of [[Immune complex|immune complexes]] are seen.
# the presence of glomerulonephritis
In 1990, the American College of Rheumatology accepted classification criteria for Granulomatosis with polyangiitis. They were not intended for diagnosis, but for inclusion in [[randomized controlled trial]]s. Two or more positive criteria have a sensitivity of 88.2% and a specificity of 92.0% of describing Granulomatosis with polyangiitis.<ref name="Leavitt">Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. ''Arthritis Rheum'' 1990;33:1101-7. PMID 2202308.</ref>
* Nasal or oral inflammation:
** painful or painless oral ulcers ''or''
** purulent or bloody nasal discharge
* Lungs: abnormal chest X-ray with:
** nodules,
** infiltrates ''or''
** cavities
* Kidneys: urinary sediment with:
** microhematuria''or''
** red cell [[urinary casts|casts]]
* Biopsy: granulomatous inflammation
** within the arterial wall ''or''
** in the perivascular area


According to the Chapel Hill Consensus Conference (CHCC) on the nomenclature of systemic vasculitis (1992), establishing the diagnosis of Granulomatosis with polyangiitis demands:<ref name="Jenette">Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG,''et al''. Nomenclature of systemic vasculitides. Proposal of an international consensus conference.''Arthritis Rheum'' 1994;37:187-92. PMID 8129773.</ref>
===== Serologic studies =====
* a granulomatous inflammation involving the respiratory tract, and
*[[ Complete blood cell count]] (CBC) with[[ differential]],
* a [[vasculitis]] of small- to medium-sized vessels.
**[[ Anemia]] can be seen in patienst with [[renal failure]] or gastrointestinal tract bleeding.
** [[Eosinophilia]] greater than 13% suggest [[Churg-Strauss disease]].
* [[Serum electrolytes]]
* BUN([[blood urea nitrogen)]]
* [[Serum creatinine]]
* [[Lactate dehydrogenase]] (LDH)
*[[ Creatine phosphokinase]] (CPK),
* The most common abnormality is an increased serum [[creatinine]] level
* Urinalysis with microscopy: Proteinuria equal to or greater than 2-3 g in 24 hours.
* Microscopic [[hematuria]]
*[[ Red cell casts]] indicates [[glomerular]] [[inflammation]]
* [[Erythrocyte sedimentation]], elevated with active disease.
* [[C-reactive protein]]: levels are elevated and correspond with disease activity.
*[[ Antinuclear antibody]] (ANA).High ANA titer is present in [[systemic lupus erythematosus]].


Several investigators have compared the ACR and Chapel Hill criteria.<ref name="Bruce">Bruce IN, Bell AL. A comparison of two nomenclature systems for primary systemic vasculitis. ''Br J Rheumatol''1997;36:453-8. PMID 9159539.</ref>
.


==References==
==References==

Latest revision as of 18:10, 27 July 2018

Rapidly progressive glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rapidly progressive glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray Findings

CT-scan Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rapidly progressive glomerulonephritis diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rapidly progressive glomerulonephritis diagnostic study of choice

CDC on Rapidly progressive glomerulonephritis diagnostic study of choice

Rapidly progressive glomerulonephritis diagnostic study of choice in the news

Blogs on Rapidly progressive glomerulonephritis diagnostic study of choice

Directions to Hospitals Treating Rapidly progressive glomerulonephritis

Risk calculators and risk factors for Rapidly progressive glomerulonephritis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2] Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3], Amandeep Singh M.D.[4],

Ahmed Elsaiey, MBBCH [5], Nazia Fuad M.D.

Overview

Rapid diagnosis of rapidly progressive glomerulonephritis is very crucial to save kidneys function. It includes blood workup and renal biopsy.Renal biopsy will provide the definitive diagnosis about the extent of involvement. Sometimes the result can be delayed ,in such cases the emperative therapy should be started to prevent end stage renal disease.

Diagnostic study of choice

Renal biopsy:

  • Renal biopsy will provide the most accurate reslt.
  • Renal biopsy will give accurate information about the extent of the disease and therapy can be planned accordingly.
Microscopic findings of RPGN Source:By Nephron - Own work[2]
Immunoflourescence
  • In type I RPGN- diffuse and linear deposition of IgG along the GBM.
  • In ttype II RPGN- diffuse and irregular deposition of IgG and C3 in the mesangial matrix.
  • In type III RPGN- no finding.
  • Electron microscopy
  • In type I and type III, no electron dense deposits are seen.
Serologic studies

.

References

  1. ↑ Jennette JC (March 2003). "Rapidly progressive crescentic glomerulonephritis". Kidney Int. 63 (3): 1164–77. doi:10.1046/j.1523-1755.2003.00843.x. PMID 12631105.
  2. ↑ https://commons.wikimedia.org/w/index.php?curid=17591464
Retrieved from "https://www.wikidoc.org/index.php?title=Rapidly_progressive_glomerulonephritis_diagnostic_study_of_choice&oldid=1485865"